Agenus Inc (NASDAQ: AGEN) on Friday, soared 6.84% from the previous trading day, before settling in for the closing price of $4.97. Within the past 52 weeks, AGEN’s price has moved between $4.78 and $42.60.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 98.93%. The company achieved an average annual earnings per share of 43.81%. With a float of $19.91 million, this company’s outstanding shares have now reached $20.95 million.
Let’s determine the extent of company efficiency that accounts for 389 employees.
Agenus Inc (AGEN) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Agenus Inc is 4.93%, while institutional ownership is 54.99%. The most recent insider transaction that took place on Feb 15 ’24, was worth 324,050. In this transaction an insider of this company bought 500,000 shares at a rate of $0.65, taking the stock ownership to the 625,969 shares. Before that another transaction happened on Nov 15 ’23, when Company’s Director bought 25,000 for $0.76, making the entire transaction worth $19,000. This insider now owns 124,063 shares in total.
Agenus Inc (AGEN) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of 22.99 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 43.81% per share during the next fiscal year.
Agenus Inc (NASDAQ: AGEN) Trading Performance Indicators
Agenus Inc (AGEN) is currently performing well based on its current performance indicators. A quick ratio of 0.44 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.71.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -13.88, a number that is poised to hit -2.82 in the next quarter and is forecasted to reach -12.91 in one year’s time.
Technical Analysis of Agenus Inc (AGEN)
Looking closely at Agenus Inc (NASDAQ: AGEN), its last 5-days average volume was 1.49 million, which is a jump from its year-to-date volume of 0.6 million. As of the previous 9 days, the stock’s Stochastic %D was 4.98%. Additionally, its Average True Range was 1.23.
During the past 100 days, Agenus Inc’s (AGEN) raw stochastic average was set at 3.77%, which indicates a significant decrease from 7.84% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 120.10% in the past 14 days, which was higher than the 114.47% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $11.75, while its 200-day Moving Average is $18.51. However, in the short run, Agenus Inc’s stock first resistance to watch stands at $5.82. Second resistance stands at $6.33. The third major resistance level sits at $6.79. If the price goes on to break the first support level at $4.85, it is likely to go to the next support level at $4.39. Now, if the price goes above the second support level, the third support stands at $3.88.
Agenus Inc (NASDAQ: AGEN) Key Stats
Market capitalization of the company is 111.24 million based on 20,946K outstanding shares. Right now, sales total 156,310 K and income totals -245,760 K. The company made 83,800 K in profit during its latest quarter, and -46,290 K in sales during its previous quarter.
